MyFinsight
Home
Blog
About
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
660.91%
Quick Ratio
660.91%
Cash Ratio
132.68%
Debt to Asset Ratio
17.39%
Unit: Thousand (K) dollars
Assets Breakdown
Short-term investments
Cash and cash equivalents
Intangible assets, in-process re...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
48,488
53,972
30,629
26,762
Short-term investments
188,388
216,957
114,108
147,375
Accounts receivable, net of allowance for doubtful accounts 375 for each period
269
58
6
179
Prepaid expenses and other current assets
4,378
4,365
3,646
4,184
Total current assets
241,523
275,352
148,389
178,500
Property and equipment, gross
116,265
99,811
82,801
69,546
Less accumulated depreciation
8,468
7,328
6,204
5,195
Property and equipment, net
107,797
92,483
76,597
64,351
Right-of-use asset
2,196
2,444
1,500
1,536
Intangible assets, in-process research and development
40,000
40,000
40,000
50,000
Other assets
509
490
486
438
Total assets
392,025
410,769
266,972
294,825
Accounts payable and accrued expenses
29,418
26,485
20,511
13,148
Lease liability
1,097
1,069
623
704
Accrued personnel expenses
5,972
3,876
7,489
6,711
Note payable
57
56
56
55
Deferred income (note 3)
-
-
0
0
Total current liabilities
36,544
31,486
28,679
20,618
Lease liability, net of current portion
1,269
1,552
1,005
971
Note payable, net of current portion
1,540
1,554
1,569
1,583
Deferred income (note 3)
26,600
26,600
26,600
26,600
Deferred tax liability
1,702
1,702
1,702
2,495
Other noncurrent liabilities
507
437
386
342
Total liabilities
68,162
63,331
59,941
52,609
Common stock 0.001 par value 750,000,000 shares authorized 114,086,092 and 74,337,990 shares issued
114
114
74
74
Additional paid-in capital
711,785
708,579
541,687
539,378
Accumulated other comprehensive (loss) income
-221
-226
110
114
Accumulated deficit
-387,815
-361,029
-334,840
-297,350
Total stockholders' equity
323,863
347,438
207,031
242,216
Total liabilities and stockholders' equity
392,025
410,769
266,972
294,825
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Short-term investments
$188,388K
(15.77%↑ Y/Y)
Cash and cash
equivalents
$48,488K
(68.08%↑ Y/Y)
Prepaid expenses and
other current assets
$4,378K
(5.37%↑ Y/Y)
Accounts receivable, net
of allowance for...
$269K
(19.56%↑ Y/Y)
Property and equipment,
gross
$116,265K
(73.48%↑ Y/Y)
Total current assets
$241,523K
(23.25%↑ Y/Y)
Property and equipment,
net
$107,797K
(72.20%↑ Y/Y)
Intangible assets,
in-process research and...
$40,000K
(-20.00%↓ Y/Y)
Right-of-use asset
$2,196K
(24.28%↑ Y/Y)
Other assets
$509K
(26.93%↑ Y/Y)
Less accumulated
depreciation
$8,468K
(91.50%↑ Y/Y)
Total assets
$392,025K
(26.16%↑ Y/Y)
Total liabilities and
stockholders' equity
$392,025K
(26.16%↑ Y/Y)
Total stockholders'
equity
$323,863K
(21.89%↑ Y/Y)
Total liabilities
$68,162K
(51.36%↑ Y/Y)
Accumulated deficit
-$387,815K
(-42.90%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$221K
(-7466.67%↓ Y/Y)
Additional paid-in capital
$711,785K
(32.55%↑ Y/Y)
Total current
liabilities
$36,544K
(181.41%↑ Y/Y)
Deferred income (note 3)
$26,600K
(0.00%↑ Y/Y)
Deferred tax liability
$1,702K
(-31.78%↓ Y/Y)
Note payable, net of
current portion
$1,540K
(-3.57%↓ Y/Y)
Lease liability, net
of current portion
$1,269K
(18.49%↑ Y/Y)
Other noncurrent
liabilities
$507K
(78.52%↑ Y/Y)
Common stock 0.001 par
value 750,000,000...
$114K
(54.05%↑ Y/Y)
Accounts payable and
accrued expenses
$29,418K
(317.40%↑ Y/Y)
Accrued personnel
expenses
$5,972K
(18.56%↑ Y/Y)
Lease liability
$1,097K
(29.52%↑ Y/Y)
Note payable
$57K
(5.56%↑ Y/Y)
Buy us a coffee